- the
development of
Aranesp (darbepoetin alfa). 1998: In
November 1998,
Immunex, a ****ure
acquisition of Amgen,
received approval for
Enbrel (etanercept)...
-
investigators also
patented the protein,
selling all
rights to its use to
Immunex, a
Seattle biotechnology company that was
acquired by
Amgen in 2002. It...
- an
American immunologist and
biotechnology entrepreneur who co-founded
Immunex Corp. and Icos Corporation, and led
Dendreon Corp. to the
development of...
- 1992)
Group Health Cooperative (acquired by
Kaiser Permanente in 2017)
Immunex (acquired by Amgen,
Thousand Oaks, California)
Muzak (now in Fort Mill...
- were produced, one in bacteria, one in
mammalian cells, and one in yeast;
Immunex developed GM-CSF
manufactured in
yeast into Leukine.
Clinical trials of...
- city,
joining biotech companies Corixa (acquired by GlaxoSmithKline),
Immunex (now part of Amgen), Trubion, and ZymoGenetics.
Vulcan Inc., the holding...
-
protein with an
identification peptide",
published 1987-10-27, ****igned to
Immunex Corp
Field J,
Nikawa J,
Broek D,
MacDonald B,
Rodgers L,
Wilson IA, Lerner...
- body. At that time,
Genetics Institute, Inc. was
working on molgramostim,
Immunex was
working on
sargramostim (Leukine), and
Sandoz was
working on regramostim...
-
companies had been
started based on
center inventions since 1975,
including Immunex and Icos. The institute's main
campus consists of 13
buildings that are...
-
human antibodies.
Abgenix partnered with
Immunex Corporation to
develop the antibody, and
Amgen acquired Immunex in 2003. In 2006,
Amgen acquired Abgenix...
